• Diagnostic system maker RSP Systems lands second financing round led by Trumpf

    The proceeds will be used to prepare for approval and market launch of its Raman spectroscopy-based glucose monitor in Europe.
    Sept. 19, 2018

    Noninvasive diagnostic system developer RSP Systems (Odense, Denmark) has completed second closing of its Series B round. This closing brings in an additional €3.85 million, bringing the round to €10.35 million in total. The proceeds will be used to fund clinical trials and to prepare for regulatory approval and market launch of its Raman spectroscopy-based glucose monitor in Europe.

    Related: RSP Systems secures new funding towards noninvasive glucose monitor

    Existing and new investors have contributed to the company's Series B round. Among these new investors is Trumpf Venture, the corporate venture arm of machine tools and lasers manufacturer Trumpf (Ditzingen, Germany).

    For more information, please visit www.rspsystems.com.

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!